Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS

Deals

Inside the 2026 Biotech Landscape: Innovation, Investment and Global Momentum

In this episode of Denatured, Jennifer Smith-Parker speaks to Kenneth Galbraith, ⁠CEO of Zymeworks and Josh Smiley, president and COO of Zai Lab, about how renewed confidence is driving biotech entering 2026.

December 18, 2025

1 min read

BioSpace Insights

influenza

Moderna Scores $54 Million From CEPI To Fund Bird Flu Vaccine

The money replaces a small portion of a contract Moderna lost when the Department of Health and Human Services canceled $760 million in backing to develop the vaccine, called mRNA-1018.

December 18, 2025

1 min read

Dan Samorodnitsky

Weigh scales on pink background, top view with space for text. Overweight concept

Obesity

Lilly’s Obesity Pill Maintains Weight Loss as Estimated Approval Timelines Inch Closer

Participants in a Phase III trial who switched to Eli Lilly’s orforglipron after 72 weeks of treatment with Wegovy or Zepbound largely maintained their weight loss for up to a year.

December 18, 2025

2 min read

Tristan Manalac

Merck & Co. headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational pharmaceutical company

Regulatory

FDA Mulls National Priority Vouchers for Two Potential Merck Blockbusters: Report

The tickets could go to the lipid-lowering pill enlicitide decanoate and the antibody-drug conjugate sacituzumab tirumotecan, though a spokesperson for the HHS did not confirm the news.

December 18, 2025

2 min read

Tristan Manalac

Orange life buoy floating in vast expanse of sea. Red lifebuoy float on ocean waves. Lifeguard equipment with rope swimming in lake. Concept of help, rescue, drowning, saving, surviving, protection

Layoffs

Voyager Throws 30 Staff Overboard After Novartis Sinks Two Programs

Novartis has discontinued two undisclosed programs under its current partership with Voyager, the biotech announced last month. Projects under the deal for spinal muscular atrophy and Huntington’s disease continue to advance.

December 18, 2025

2 min read

Tristan Manalac

Reaching an agreement. Businessmen shake hands and make a deal. vector

Collaboration

GSK Makes $400M+ RNA Play With CAMP4 Collab, Targets Neuro, Kidney Diseases

The Massachusetts biotech will also be eligible to milestone payments, though the exact amount has yet to be disclosed.

December 18, 2025

1 min read

Tristan Manalac

Contemporary art collage. Creative design. Group of young people, employees walking down to start new business. Personal growth. Concept of business, career development, success, growth, occupation

Leadership

The Four Employment Agreement Questions Every Pharma Executive Must Ask

Clarity on employment terms is essential to protect careers. In this column, Kaye/Bassman’s Michael Pietrack speaks to employment attorney Howard Matalon, JD, partner at OlenderFeldman, on how to evaluate the fine print of an employment agreement.

December 18, 2025

6 min read

Michael Pietrack

Job Trends

8 Companies Hiring in Greater Philadelphia

If you’re looking for a biopharma job in Philadelphia, here are eight companies on BioSpace hiring right now.

December 18, 2025

1 min read

Chantal Dresner

2006 James Gathany Captured by James Gathany, Centers for Disease Control's biomedical photographer, this 2006 image depicted the exterior of the new "Tom Harkin Global Communications Center", otherwise known as Building 19, located on the organization's Roybal Campus in Atlanta, Georgia. The facility houses the CDC's Information Center/Library, auditoria and meeting halls, which are used to accommodate in-house staff meetings, and national/international conferences hosted by the CDC, and the National Center for Health Marketing's, Division of Creative Services, which includes a full service television broadcast facility. The exhibit area currently features the "Global Symphony", the first of several permanently installed exhibitions, and changing exhibitions that focus on a variety of public health topics. The exhibits in the Center are self-guided, and require no advance reservations. Additional curriculum-based exhibits and programming will be added in the future. Tom Harkin Global Communications Center Exhibit Area Centers for Disease Control and Prevention - 1600 Clifton Road, N.E., Atlanta, Georgia 30333 - Hours: Monday Friday, 9 am 5 pm, except for federal holidays Admission is free - Government-issue photo ID is required for entry. Please note that CDC is a working federal facility and as such does not provide public tours of its campus and laboratories. - For more information please call 404-639-0830.

Vaccines

CDC Formally Adopts Delayed Hepatitis B Vaccine Dose

The CDC accepted the recommendation of its advisory committee that the shot be delayed for many patients until they are at least two months of age due to safety concerns. The CDC itself has said the vaccine is safe and effective.

December 17, 2025

4 min read

Tristan Manalac

Visit website

Email Us

IN THE PRESS

Press Releases

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer

June 2, 2025

4 min read

BioMidwest

Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings